Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Liver Diseases

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 67 articles: HTML format Text format

Single Articles

February 2012
1. MORIMOTO M , Numata K, Moriya S, Kondo M, et al
   Inflammation-based Prognostic Score for Hepatocellular Carcinoma Patients on Sorafenib Treatment.
   Anticancer Res. 2012;32:619-23.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. CHUN YH , Ahn SH, Park JY, Kim DY, et al
   Clinical Characteristics and Treatment Outcomes of Hepatocellular Carcinoma with Inferior Vena Cava/Heart Invasion.
   Anticancer Res. 2011;31:4641-4646.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GIORGIO A , Calisti G, DE Stefano G, Farella N, et al
   Radiofrequency ablation for intrahepatic cholangiocarcinoma: retrospective analysis of a single centre experience.
   Anticancer Res. 2011;31:4575-80.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. VITALE FV , Romeo P, DI Maggio EM, Parisi A, et al
   Initial experience with hepatic intraarterial fotemustine and interferon alpha 2b combination for treatment of liver tumors.
   Anticancer Res. 2011;31:4553-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. SHAO YY , Chen PJ, Lin ZZ, Huang CC, et al
   Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma.
   Anticancer Res. 2011;31:4007-11.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KUROKAWA T , Yamazaki S, Moriguchi M, Aoki M, et al
   Resection of solitary metachronous lymph node metastasis from hepatocellular carcinoma following transarterial chemotherapy with Cisplatin: a case report.
   Anticancer Res. 2011;31:3991-3.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. GIORGIO A , Calisti G, DI Sarno A, Farella N, et al
   Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound.
   Anticancer Res. 2011;31:3977-82.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. POGGI G , Montagna B, Melchiorre F, Quaretti P, et al
   Hepatic Intra-arterial Cetuximab in Combination with 5-Fluorouracil and Cisplatin as Salvage Treatment for Sorafenib-refractory Hepatocellular Carcinoma.
   Anticancer Res. 2011;31:3927-33.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. HOFFMANN K , Shibo L, Xiao Z, Longerich T, et al
   Correlation of Gene Expression of ATP-binding Cassette Protein and Tyrosine Kinase Signaling Pathway in Patients with Hepatocellular Carcinoma.
   Anticancer Res. 2011;31:3883-90.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
10. SHI Y , Zheng L, Luo G, Wei J, et al
    Expression of zinc finger 23 gene in human hepatocellular carcinoma.
    Anticancer Res. 2011;31:3595-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. SHELINE CT
    Thiamine Supplementation Attenuated Hepatocellular Carcinoma in the Atp7b Mouse Model of Wilson's Disease.
    Anticancer Res. 2011;31:3395-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. KURAMITSU Y , Takashima M, Yokoyama Y, Iizuka N, et al
    Up-regulation of 42 kDa Tubulin Alpha-6 Chain Fragment in Well-differentiated Hepatocellular Carcinoma Tissues from Patients Infected with Hepatitis C Virus.
    Anticancer Res. 2011;31:3331-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
13. OKABE K , Beppu T, Haraoka K, Oh-Uchida Y, et al
    Safety and Short-term Therapeutic Effects of Miriplatin-Lipiodol Suspension in Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma.
    Anticancer Res. 2011;31:2983-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. GUNDLING F , Seidl H, Schmidtler F, Loffler N, et al
    Nonhepatic Cancer in Liver Cirrhosis: A Retrospective Study of Prevalence, Complication Rate after Specific Oncological Treatment, Follow-up and Prognostic Predictors of Outcome in 354 Patients with Cirrhosis.
    Anticancer Res. 2011;31:2931-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. HENDERSON-JACKSON EB , Helm J, Strosberg J, Nasir NA, et al
    Palladin is a marker of liver metastasis in primary pancreatic endocrine carcinomas.
    Anticancer Res. 2011;31:2957-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
16. COLLETTINI F , Poellinger A, Schnapauff D, Denecke T, et al
    CT-Guided High-Dose-Rate Brachytherapy of Metachronous Ovarian Cancer Metastasis to the Liver: Initial Experience.
    Anticancer Res. 2011;31:2597-602.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
17. MORISAKI T , Onishi H, Koya N, Kiyota A, et al
    Combinatorial Cytotoxicity of Gemcitabine and Cytokine-activated Killer Cells in Hepatocellular Carcinoma via the NKG2D-MICA/B System.
    Anticancer Res. 2011;31:2505-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
18. GIORGIO A , DI Sarno A, DE Stefano G, Scognamiglio U, et al
    Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an italian randomized controlled trial.
    Anticancer Res. 2011;31:2291-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. KURAMITSU Y , Zhang X, Wang Y, Nakamura K, et al
    Identification of Differentially Expressed Proteins in Tumour Necrosis Factor-alpha-resistant and -sensitive Rat Hepatoma Cells.
    Anticancer Res. 2011;31:2059-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. BABSKY AM , Ju S, George B, Bennett S, et al
    Predicting response to benzamide riboside chemotherapy in hepatocellular carcinoma using apparent diffusion coefficient of water.
    Anticancer Res. 2011;31:2045-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. CHANG KW , Chou A, Lee CC, Yeh C, et al
    Overexpression of {kappa}-Actin Alters Growth Properties of Hepatoma Cells and Predicts Poor Postoperative Prognosis.
    Anticancer Res. 2011;31:2037-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. MIYATA Y , Sagara Y, Matsuo T, Ohba K, et al
    Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review.
    Anticancer Res. 2011;31:2335-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. MUSA MA , Badisa VL, Latinwo LM, Cooperwood J, et al
    Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines.
    Anticancer Res. 2011;31:2017-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
24. MAYRHAUSER U , Stiegler P, Stadlbauer V, Koestenbauer S, et al
    Effect of hyperthermia on liver cell lines: important findings for thermal therapy in hepatocellular carcinoma.
    Anticancer Res. 2011;31:1583-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. OCVIRK J , Rebersek M, Boc M
    Bevacizumab in First-line Therapy of Metastatic Colorectal Cancer: A Retrospective Comparison of FOLFIRI and XELIRI.
    Anticancer Res. 2011;31:1777-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. RAJENDRAN S , Collins S, van Pijkeren JP, O'Hanlon D, et al
    Targeting of breast metastases using a viral gene vector with tumour-selective transcription.
    Anticancer Res. 2011;31:1627-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
27. KITAMURA Y , Shirahata A, Sakuraba K, Goto T, et al
    Aberrant methylation of the vimentin gene in hepatocellular carcinoma.
    Anticancer Res. 2011;31:1289-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. LAI LJ , Ho TC
    Pigment Epithelial-derived Factor Inhibits c-FLIP Expression and Assists Ciglitazone-induced Apoptosis in Hepatocellular Carcinoma.
    Anticancer Res. 2011;31:1173-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SPRATLIN JL , Pitts TM, Kulikowski GN, Morelli MP, et al
    Synergistic activity of histone deacetylase and proteasome inhibition against pancreatic and hepatocellular cancer cell lines.
    Anticancer Res. 2011;31:1093-103.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. LISKA V , Holubec L Jr, Treska V, Vrzalova J, et al
    Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer.
    Anticancer Res. 2011;31:1447-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. BANDAPALLI OR , Hariri N, Macher-Goppinger S, Kahlert C, et al
    Increased apoptosis of host cells and tumor cells in the invasion front of colorectal liver metastases.
    Anticancer Res. 2011;31:1215-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. SILVA SR , Zaytseva YY, Jackson LN, Lee EY, et al
    The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON.
    Anticancer Res. 2011;31:1153-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
33. NOJIRI K , Nagano Y, Tanaka K, Ueda M, et al
    The Influence of Viral Hepatitis Status on Long-term HCC Outcome in Patients with Non-cirrhotic Livers.
    Anticancer Res. 2011;31:1055-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. SHIRAHATA A , Fan W, Sakuraba K, Yokomizo K, et al
    MACC 1 as a Marker for Vascular Invasive Hepatocellular Carcinoma.
    Anticancer Res. 2011;31:777-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. NOJIRI K , Tanaka K, Nagano Y, Ueda M, et al
    Efficacy of Surgery for Lung Metastases from Colorectal Cancer Synchronous to or Following that for Liver Metastases.
    Anticancer Res. 2011;31:1049-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. TZOVARAS AA , Karagiannis A, Margari C, Barla G, et al
    Effective Panitumumab Treatment in Patients with Heavily Pre-treated Metastatic Colorectal Cancer: A Case Series.
    Anticancer Res. 2011;31:1033-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
37. JIANG J , Wu C, Shen Y, Xu B, et al
    Clinical Application of Determining Serum AFP-IgM Complexes for Diagnosis of Small Hepatocellular Carcinoma.
    Anticancer Res. 2011;31:687-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. WAKABAYASHI N , Okabe K, Hayashi M, Honoki K, et al
    Mutations and aberrant transcriptions of Stk11 (Lkb1) gene in rat liver tumors.
    Anticancer Res. 2011;31:543-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
39. POHLEN U , Buhr HJ, Berger G
    Improvement of Biodistribution with PEGylated Liposomes Containing Docetaxel with Degradable Starch Microspheres for Hepatic Arterial Infusion in the Treatment of Liver Metastases: A Study in CC-531 Liver Tumor-bearing WAG RIJ Rats.
    Anticancer Res. 2011;31:153-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. POHLEN U , Reszka R, Buhr HJ, Berger G, et al
    Hepatic Arterial Infusion in the Treatment of Liver Metastases with PEG Liposomes in Combination with Degradable Starch Microspheres (DSM) Increases Tumor 5-FU Concentration. An Animal Study in CC-531 Liver Tumor-bearing Rats.
    Anticancer Res. 2011;31:147-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. FREYER G , Duret A, Milano G, Chatelut E, et al
    Pharmacogenetic Tailoring of Irinotecan-based First-line Chemotherapy in Metastatic Colorectal Cancer: Results of a Pilot Study.
    Anticancer Res. 2011;31:359-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. HENDLER K , Pe'er J, Kaiserman I, Baruch R, et al
    Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2).
    Anticancer Res. 2011;31:351-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. BARAK V , Kaiserman I, Frenkel S, Hendler K, et al
    The dynamics of serum tumor markers in predicting metastatic uveal melanoma (part 1).
    Anticancer Res. 2011;31:345-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. TRESKA V , Topolcan O, Vrzalova J, Skalicky T, et al
    Predictive value of serum biomarkers in patients after portal vein embolization (PVE): a pilot study.
    Anticancer Res. 2011;31:339-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ADVANI PP , Fakih MG
    5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
    Anticancer Res. 2011;31:335-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. TAMURA S , Oshima T, Yoshihara K, Kanazawa A, et al
    Clinical Significance of STC1 Gene Expression in Patients with Colorectal Cancer.
    Anticancer Res. 2011;31:325-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. WASA J , Sugiura H, Kozawa E, Kohyama K, et al
    The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model.
    Anticancer Res. 2011;31:123-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SAKURABA K , Yokomizo K, Shirahata A, Goto T, et al
    TIP60 as a Potential Marker for the Malignancy of Gastric Cancer.
    Anticancer Res. 2011;31:77-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
49. KIM SJ , Han SW, Oh DY, Yi NJ, et al
    Combination Chemotherapy with S-1 and Platinum in Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2010;30:5245-5250.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. POGGI G , Pozzi E, Riccardi A, Tonini S, et al
    Complications of Image-guided Transcatheter Hepatic Chemoembolization of Primary and Secondary Tumours of the Liver.
    Anticancer Res. 2010;30:5159-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. BANG MH , VAN Riep T, Thinh NT, Song LH, et al
    Arabinoxylan Rice Bran (MGN-3) Enhances the Effects of Interventional Therapies for the Treatment of Hepatocellular Carcinoma: A Three-year Randomized Clinical Trial.
    Anticancer Res. 2010;30:5145-5151.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. FUJIWARA Y , Shiba H, Furukawa K, Iida T, et al
    Glasgow Prognostic Score Is Related to Blood Transfusion Requirements and Post-operative Complications in Hepatic Resection for Hepatocellular Carcinoma.
    Anticancer Res. 2010;30:5129-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. KOBAYASHI N , Koizumi T, Eguchi T, Hyogotani A, et al
    A Mediastinal Somatic-type Germ Cell Tumor with Hepatic Metastasis Successfully Treated by Multiple Modalities.
    Anticancer Res. 2010;30:5117-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SUZUKI M , Sugimoto K, Tanaka J, Tameda M, et al
    Up-regulation of Glypican-3 in Human Hepatocellular Carcinoma.
    Anticancer Res. 2010;30:5055-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. GEDALY R , Angulo P, Hundley J, Daily MF, et al
    PI-103 and Sorafenib Inhibit Hepatocellular Carcinoma Cell Proliferation by Blocking Ras/Raf/MAPK and PI3K/AKT/mTOR Pathways.
    Anticancer Res. 2010;30:4951-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. MARLER L , Conda-Sheridan M, Cinelli MA, Morrell AE, et al
    Cancer chemopreventive potential of aromathecins and phenazines, novel natural product derivatives.
    Anticancer Res. 2010;30:4873-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
57. HOFFMANN K , Franz C, Xiao Z, Mohr E, et al
    Sorafenib Modulates the Gene Expression of Multi-drug Resistance Mediating ATP-Binding Cassette Proteins in Experimental Hepatocellular Carcinoma.
    Anticancer Res. 2010;30:4503-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. MITSELOU A , Karapiperides D, Nesseris I, Vougiouklakis T, et al
    Altered expression of cell cycle and apoptotic proteins in human liver pathologies.
    Anticancer Res. 2010;30:4493-501.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
59. KUBO E , Yoshikawa N, Kunitomo M, Kagota S, et al
    Inhibitory effect of Cordyceps sinensis on experimental hepatic metastasis of melanoma by suppressing tumor cell invasion.
    Anticancer Res. 2010;30:3429-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
60. CHEN Y , Yan Z, Wang J, Wang X, et al
    Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer.
    Anticancer Res. 2010;30:3045-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. CHUA TC , Bester L, Akther J, Morris DL, et al
    Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases.
    Anticancer Res. 2010;30:3005-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. TSUMURAYA M , Kato H, Miyachi K, Sasaki K, et al
    Comprehensive analysis of genes involved in the malignancy of gastrointestinal stromal tumors.
    Anticancer Res. 2010;30:2705-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. YAMADA T , Oshima T, Yoshihara K, Tamura S, et al
    Overexpression of MMP-13 Gene in Colorectal Cancer with Liver Metastasis.
    Anticancer Res. 2010;30:2693-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
64. MAKINO H , Kunisaki C, Izumisawa Y, Tokuhisa M, et al
    Indication for hepatic resection in the treatment of liver metastasis from gastric cancer.
    Anticancer Res. 2010;30:2367-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. KORITA PV , Wakai T, Ajioka Y, Inoue M, et al
    Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma.
    Anticancer Res. 2010;30:2279-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. PASCHOS KA , Bird NC
    Liver regeneration and its impact on post-hepatectomy metastatic tumour recurrence.
    Anticancer Res. 2010;30:2161-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. KASPER HU , Konze E, Dienes HP, Stippel DL, et al
    COX-2 expression and effects of COX-2 inhibition in colorectal carcinomas and their liver metastases.
    Anticancer Res. 2010;30:2017-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: